Form 4: Intensity Therapeutics Officer Acquires Stock Options
SEC Form 4 Filing
John M. Wesolowski, Principal Accounting Officer and Controller of Intensity Therapeutics, Inc., acquired stock options for 25,000 shares on March 6, 2024.
Summary
- On March 6, 2024, John M. Wesolowski, Principal Accounting Officer and Controller of Intensity Therapeutics, Inc., acquired stock options for 25,000 shares of common stock.
- The exercise price of the stock options is $5.19.
- The options vest in four equal annual installments beginning on March 6, 2025, subject to continued employment.
- The options expire on March 6, 2034.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to stock option grants. It doesn't contain overtly positive or negative information, but the granting of options to an officer is generally viewed as a neutral to slightly positive sign.
Positives
- The acquisition of stock options by an officer could indicate confidence in the company's future performance.
Industry Context
Stock option grants are a common form of compensation for company officers, aligning their interests with those of shareholders.
Stakeholder Impact
- The stock option grant could potentially incentivize the officer to improve company performance, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of stock option grant |
| 03/06/2025 | First vesting date for the stock options |
| 03/06/2034 | Expiration date of the stock options |
| 03/07/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.